Whitehawk Therapeutics (WHWK) Change in Cash (2010 - 2026)
Whitehawk Therapeutics' (WHWK) quarterly Change in Cash came in at -$2.8 million in Q1 2026, down 101.4% year-on-year from $198.8 million in Q1 2025, and down 665.29% on a QoQ basis from -$363000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) Change in Cash (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 17 years of Change in Cash data on file, last reported at -$2.8 million in Q1 2026.
- On a quarterly basis, Change in Cash fell 101.4% year-over-year to -$2.8 million in Q1 2026; TTM through Mar 2026 was -$192.8 million, a 210.97% decrease from a year earlier, with the FY2025 full-year figure at $8.8 million, up 125.82% from the prior year.
- Change in Cash for Q1 2026 stood at -$2.8 million, down from -$363000.0 in the prior quarter.
- Over the last five years, Change in Cash for WHWK reached as high as $198.8 million in Q1 2025 and fell as low as -$107.0 million in Q3 2025.
- Historically, Change in Cash has averaged -$6.7 million across 5 years, with a median of -$5.9 million in 2023.
- Across the five-year window, Change in Cash sank 1753.98% in 2024 and surged 2283.08% in 2025, its largest moves.
- Year by year, Change in Cash stood at -$95.8 million in 2022, then soared by 93.83% to -$5.9 million in 2023, then jumped by 68.44% to -$1.9 million in 2024, then jumped by 80.56% to -$363000.0 in 2025, then slumped by 665.29% to -$2.8 million in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were -$2.8 million in Q1 2026, -$363000.0 in Q4 2025, and -$107.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - | -2.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.78 Mn |
| Dec 31, 2025 | -363,000.00 |
| Sep 30, 2025 | -107.01 Mn |
| Jun 30, 2025 | -82.63 Mn |
| Mar 31, 2025 | 198.84 Mn |
| Dec 31, 2024 | -1.87 Mn |
| Sep 30, 2024 | -10.60 Mn |
| Jun 30, 2024 | -12.64 Mn |
| Mar 31, 2024 | -9.11 Mn |
| Dec 31, 2023 | -5.92 Mn |
| Sep 30, 2023 | 641,000.00 |
| Jun 30, 2023 | 34.12 Mn |
| Mar 31, 2023 | -4.97 Mn |
| Dec 31, 2022 | -95.80 Mn |
| Sep 30, 2022 | 16.08 Mn |
| Jun 30, 2022 | -11.05 Mn |
| Mar 31, 2022 | -19.14 Mn |
| Dec 31, 2021 | -12.39 Mn |
| Sep 30, 2021 | 149.70 Mn |
| Jun 30, 2021 | -3.34 Mn |